Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)

Vietnam · Delayed Price · Currency is VND

51,400

+200 (0.39%)

At close: Jul 3, 2026

-5.34% (1Y)

Market Cap	4.86T -5.4%
Revenue (ttm)	1.87T +4.9%
Net Income	250.31B +0.8%
EPS	2,649.09 -1.1%
Shares Out	94.49M
PE Ratio	19.40
Forward PE	19.57
Dividend	2,000.00 (3.91%)
Ex-Dividend Date	n/a

Volume	8,919
Open	50,200
Previous Close	51,200
Day's Range	50,200 - 51,600
52-Week Range	46,600 - 57,000
Beta	0.02
Analysts	Buy
Price Target	63,500.00 (+23.54%)
Earnings Date	Jul 27, 2026

About HOSE:DBD

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous system drugs; vitamins and minerals; endocrine hormones; respiratory drugs; antifungal and antiviral drugs; dermatologic drugs; antidotes; and drugs fo... [Read more]

Industry Pharmaceutical Preparations

Founded 1976

Employees 1,423

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol DBD

Full Company Profile

Financial Performance

In 2025, HOSE:DBD's revenue was 1.87 trillion, an increase of 7.98% compared to the previous year's 1.73 trillion. Earnings were 251.02 billion, an increase of 6.07%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for DBD stock is "Buy." The 12-month stock price target is ₫63,500, which is an increase of 23.54% from the latest price.

Price Target

₫63,500

(23.54% upside)

Analyst Consensus: Buy

Stock Forecasts